Pharma Journalist 9027 posts 0 comments

Atreca, Inc. a clinical-stage biotechnology company focused on developing novel therapeutics generated through a unique discovery platform based on interrogation of the active human…
Read More...

Pfizer Inc. and BioNTech SE announced topline results from a Phase 3 randomized, controlled trial evaluating the efficacy and safety of a 30-µg booster dose of the Pfizer-BioNTech…
Read More...

Oncodesign, a French biopharmaceutical company specialized in kinase inhibitor research and precision medicine, and TiumBio a company specializing in R&D for rare diseases, have…
Read More...

SMi Reports: Registration is open for SMi’s 14th Annual Conference and Exhibition taking place between 12th-13th January 2022 in London, UK. The pre-filled syringes industry is…
Read More...

Biotage AB (publ) has entered into an agreement to acquire all outstanding shares in the privately held company ATDBio Limited based in Oxford and Southampton, UK, for a total purchase…
Read More...

BeiGene, a global, science-driven biotechnology company focused on developing innovative and affordable medicines to improve treatment outcomes and access for patients worldwide, and…
Read More...

Moderna, Inc. a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, announced that the U.S. Food and Drug Administration (FDA) has authorized for emergency…
Read More...

Moleculin Biotech, Inc. (Moleculin or the Company), a clinical stage pharmaceutical company with a broad portfolio of drug candidates targeting highly resistant tumors and viruses,…
Read More...

Amgen announced that it has successfully completed its previously announced acquisition of Teneobio, Inc. (Teneobio). Effective as of Oct. 19, 2021, Amgen has acquired all outstanding…
Read More...

SMi Reports: Conference Chair Di Morris, AstraZeneca invites industry experts to attend the 10th Anniversary of Pharmaceutical Microbiology UK Conference taking place in London on 17-18…
Read More...